ATE392900T1 - Verwendung unverdaulicher, polymerer schäume zum abkapseln eingenommener stoffe, und dadurch verhinderung ihre aufnahme durch den körper - Google Patents

Verwendung unverdaulicher, polymerer schäume zum abkapseln eingenommener stoffe, und dadurch verhinderung ihre aufnahme durch den körper

Info

Publication number
ATE392900T1
ATE392900T1 AT02715032T AT02715032T ATE392900T1 AT E392900 T1 ATE392900 T1 AT E392900T1 AT 02715032 T AT02715032 T AT 02715032T AT 02715032 T AT02715032 T AT 02715032T AT E392900 T1 ATE392900 T1 AT E392900T1
Authority
AT
Austria
Prior art keywords
enapsule
indigestible
absorption
preventing
polymeric foam
Prior art date
Application number
AT02715032T
Other languages
English (en)
Inventor
Bryn Hird
Ronald Jandacek
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Application granted granted Critical
Publication of ATE392900T1 publication Critical patent/ATE392900T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/745—Polymers of hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/745—Polymers of hydrocarbons
    • A61K31/75—Polymers of hydrocarbons of ethene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02715032T 2001-03-19 2002-03-01 Verwendung unverdaulicher, polymerer schäume zum abkapseln eingenommener stoffe, und dadurch verhinderung ihre aufnahme durch den körper ATE392900T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27705801P 2001-03-19 2001-03-19

Publications (1)

Publication Number Publication Date
ATE392900T1 true ATE392900T1 (de) 2008-05-15

Family

ID=23059227

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02715032T ATE392900T1 (de) 2001-03-19 2002-03-01 Verwendung unverdaulicher, polymerer schäume zum abkapseln eingenommener stoffe, und dadurch verhinderung ihre aufnahme durch den körper

Country Status (13)

Country Link
US (1) US20030072804A1 (de)
EP (1) EP1372673B1 (de)
JP (1) JP4477826B2 (de)
CN (1) CN1296053C (de)
AR (1) AR033871A1 (de)
AT (1) ATE392900T1 (de)
AU (1) AU2002247253B2 (de)
CA (1) CA2437481C (de)
DE (1) DE60226217T2 (de)
ES (1) ES2303545T3 (de)
MX (1) MXPA03008499A (de)
MY (1) MY134067A (de)
WO (1) WO2002074343A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8372430B2 (en) 2002-12-17 2013-02-12 The Procter & Gamble Company Compositions, methods, and kits useful for the alleviation of gastrointestinal effects
ES2343890T3 (es) * 2003-09-08 2010-08-12 Fmc Biopolymer As Espuma gelificada a base de biopolimero.
WO2005074378A2 (en) * 2004-02-10 2005-08-18 Itzhak Katz Device and method for reducing calorie intake
US20080089933A1 (en) * 2006-10-16 2008-04-17 Amir Alon Device and method for reducing calorie intake
EP1931319A2 (de) * 2005-08-09 2008-06-18 Tylerton International Inc. Sättigung
WO2012061422A2 (en) * 2010-11-02 2012-05-10 The Johns Hopkins University Gastric sponge system and use thereof
WO2012125297A1 (en) 2011-03-01 2012-09-20 The Procter & Gamble Company Porous disintegratable solid substrate for personal health care applications
US8722066B2 (en) * 2011-03-29 2014-05-13 Primigenia, LLC Devices and methods for weight control and weight loss
WO2013148359A1 (en) * 2012-03-27 2013-10-03 Teratekne, Inc. High porosity cellulosic sponge
EP2916913A4 (de) * 2012-03-27 2016-03-02 Primigenia Llc Hochporöser cellulosischer schwamm
CN104622851B (zh) * 2015-03-13 2017-09-12 山东省药学科学院 一种减肥胶囊及其制备方法
WO2017031468A1 (en) * 2015-08-20 2017-02-23 The Johns Hopkins University Gastric device and method of use thereof

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3600186A (en) * 1968-04-23 1971-08-17 Procter & Gamble Low calorie fat-containing food compositions
GB1302548A (de) * 1969-07-28 1973-01-10
US3980770A (en) * 1971-06-04 1976-09-14 Pharmacia Aktiebolag Polymerization products containing amino groups useful in serum cholesterol level control
US3923972A (en) * 1971-10-12 1975-12-02 Monsanto Co Method of lowering blood cholesterol level
US4211765A (en) * 1971-10-12 1980-07-08 Monsanto Company Method for controlling obesity
US4039489A (en) * 1972-02-22 1977-08-02 Nasa Oil and fat absorbing polymers
FI54811C (fi) * 1972-06-03 1979-03-12 Vega Jose Manuel Regife Foerfarande foer tillvaratagning och rening av zink fraon zinkhaltiga loesningar
US3980968A (en) * 1975-01-02 1976-09-14 Zenith Radio Corporation Non-proportionate AFC system
US4005195A (en) * 1976-02-12 1977-01-25 The Procter & Gamble Company Compositions for treating hypercholesterolemia
US4223023A (en) * 1978-10-12 1980-09-16 Ivan Furda Nonabsorbable lipid binder
FR2485548A1 (fr) * 1980-06-30 1981-12-31 Lhd Lab Hygiene Dietetique Procede de preparation d'un polymere de structure tridimensionnelle du type polyurethane reticule, produit obtenu selon ce procede et son application en tant qu'agent gonflant, notamment en therapeutique
US4432968A (en) * 1980-10-20 1984-02-21 The Dow Chemical Company Weight control with fat imbibing polymers
US4401682A (en) * 1981-07-31 1983-08-30 Battista Orlando A Expandable low calorie compositions
CA1247547A (en) * 1983-06-22 1988-12-28 Paul Hadvary Leucine derivatives
US6077556A (en) * 1989-04-10 2000-06-20 The Procter & Gamble Company Solid, nondigestible, fat-like compounds
US5603950A (en) * 1990-08-14 1997-02-18 Ratjen; Werner Agent for oral intake
US5268224A (en) * 1991-08-12 1993-12-07 The Procter & Gamble Company Absorbent foam materials for aqueous body fluids and absorbent articles containing such materials
US5260345A (en) * 1991-08-12 1993-11-09 The Procter & Gamble Company Absorbent foam materials for aqueous body fluids and absorbent articles containing such materials
JP2667351B2 (ja) * 1992-03-24 1997-10-27 麒麟麦酒株式会社 食餌脂質消化吸収阻害剤および飲食品
CA2098167C (en) * 1992-06-24 2006-12-19 Dorothea Isler Foodstuffs and feedstuffs containing a lipase inhibitor
ES2105342T3 (es) * 1992-10-30 1997-10-16 Procter & Gamble Composiciones de grasa no digerible que contienen un polimero de poliester de poliol solido para el control de la perdida pasiva de aceite.
ATE140591T1 (de) * 1992-10-30 1996-08-15 Procter & Gamble Unverdauliche, eine co-kristallisierte mischung von polyol polyester und kristallmodifiziermittel enthaltende fettmischung mit passiver ölverlustkontrolle
US5290820A (en) * 1993-07-29 1994-03-01 Shell Oil Company Process for preparing low density porous crosslinked polymeric materials
US5563179A (en) * 1995-01-10 1996-10-08 The Proctor & Gamble Company Absorbent foams made from high internal phase emulsions useful for acquiring and distributing aqueous fluids
US5650222A (en) * 1995-01-10 1997-07-22 The Procter & Gamble Company Absorbent foam materials for aqueous fluids made from high internal phase emulsions having very high water-to-oil ratios
US5750585A (en) * 1995-04-04 1998-05-12 Purdue Research Foundation Super absorbent hydrogel foams
US6271278B1 (en) * 1997-05-13 2001-08-07 Purdue Research Foundation Hydrogel composites and superporous hydrogel composites having fast swelling, high mechanical strength, and superabsorbent properties
US6048908A (en) * 1997-06-27 2000-04-11 Biopore Corporation Hydrophilic polymeric material
DE19739031A1 (de) * 1997-09-05 1999-03-11 Suwelack Nachf Dr Otto Mittel zur peroralen Verabreichung, seine Herstellung und Verwendung
DE69916288T2 (de) * 1998-08-14 2005-03-24 F. Hoffmann-La Roche Ag Lipasehemmer und chitosan enthaltende arzneimittel
ATE324801T1 (de) * 1999-09-06 2006-06-15 Guenther Beisel Vernetztes mittel zur erzeugung eines langanhaltenden sättigungseffekts und verfahren zu dessen herstellung
WO2001017510A1 (de) * 1999-09-06 2001-03-15 Beisel Guenther Mittel zur stimulanz der darmtätigkeit sowie verfahren zu dessen herstellung
DE19942365A1 (de) * 1999-09-06 2001-03-15 Guenther Beisel Mittel zur Stimulanz der Darmtätigkeit sowie Verfahren zu dessen Herstellung
US6251421B1 (en) * 2000-09-25 2001-06-26 Sarfaraz K. Niazi Pharmaceutical composition containing psyllium fiber and a lipase inhibitor
DE10062624A1 (de) * 2000-12-15 2002-06-20 Werner Ratjen Oral verabreichbarer Stoff mit schwammartiger Struktur

Also Published As

Publication number Publication date
EP1372673B1 (de) 2008-04-23
CA2437481A1 (en) 2002-09-26
HK1069329A1 (en) 2005-05-20
EP1372673A2 (de) 2004-01-02
JP2004526732A (ja) 2004-09-02
AU2002247253B2 (en) 2006-02-02
DE60226217D1 (de) 2008-06-05
WO2002074343A2 (en) 2002-09-26
MXPA03008499A (es) 2003-12-08
CA2437481C (en) 2010-11-02
WO2002074343A3 (en) 2003-03-13
CN1296053C (zh) 2007-01-24
CN1531437A (zh) 2004-09-22
US20030072804A1 (en) 2003-04-17
AR033871A1 (es) 2004-01-07
JP4477826B2 (ja) 2010-06-09
ES2303545T3 (es) 2008-08-16
DE60226217T2 (de) 2009-05-14
MY134067A (en) 2007-11-30

Similar Documents

Publication Publication Date Title
MX276488B (es) Regeneracion de fluidos de tratamiento que contienen gas acido.
MX285679B (es) Composicion de resina absorbente de agua y metodo de produccion de la misma.
IS8267A (is) [1,8]naftýridín-2-ón og tengd efnasambönd til notkunar við meðferð á geðklofa
PT1507498E (pt) Corpo absorvente para aplicar no corpo humano
DK1298281T3 (da) Stimulering ved syrebehandling med en skumblanding i borehullet
DE60308431D1 (de) Geschäumte Säurebehandlungsflüssigkeit
DK1684823T3 (da) Sikkerhedsspinalkateter
IL174994A0 (en) Pyrimidin - 4 - yl - 3, 4 - thione compounds and their use in therapy
WO2004074243A3 (en) Heterocyclyl-3-sulfonylindazoles as 5-hydroxytryptamine-6 ligands
EP1770069A4 (de) Wasserreiniger
CY1108808T1 (el) Ενωσεις μοτιλιδης
MXPA03008634A (es) Nuevos compuestos de dihidropirimidina ciano sustituidos y su uso para tratar enfermedades.
ATE502035T1 (de) 2-amido-4-phenylthiazol-derivate, ihre herstellung und ihre therapeutische verwendung
GB0524182D0 (en) Novel nanocomposites and their application as monolith columns
DK1670482T4 (da) Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme
DE60226217D1 (de) Verwendung unverdaulicher, polymerer schäume zum abkapseln eingenommener stoffe, und dadurch verhinderung ihre aufnahme durch den körper
GB0416412D0 (en) Photo-electronic water purifier
EP1751259A4 (de) Piezoelektrisches generatorsystem mit einer energiespeicherung
AU2003281683A8 (en) Emulsified water/hydrocarbon fuel, preparation and uses thereof
ZA200501288B (en) Substituted 5-chroman-5-yl-ethylamine compounds and their use for the treatment of glaucoma.
WO2006088797A3 (en) Portable water purifier
ZA200509966B (en) The treatment of water containing dissolved gases
GB0314242D0 (en) Fluid treatment
GB2409159B (en) A preparation for use in the treatment of mud fever in horses
EP1725869A4 (de) Man2as als modifikatoren des iger-wegs und verwendungsverfahren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties